nadobanya

Двойное дно , отработает и будем расти .

Long
nadobanya Aggiornato   
NASDAQ:BTAI   BioXcel Therapeutics, Inc.
Почти отработало двойное дно . Ждем 24 цену.
с 5 января перенесли рассм лекарства на апрель
если будет ралли , то сценарий отработает
Ordine annullato:
Двойное дно не сработало, и улетели вниз . Теперь не смотрим на ТА , ждем новостей про лектарство в апреле .
Commento:
NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will present at the upcoming SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16 at 2:20 p.m. ET. Dr. Mehta will highlight the Company’s neuroscience and immuno-oncology programs, artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process, and its commercial and launch readiness plans for BXCL501.
Trade chiuso manualmente
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.